OnCore Login

News & Developments

Across the Consortium – September 2017

Sept. 20, 2017:

Each month, the Big Ten Cancer Research Consortium highlights advances in research and treatment led by our member institutions. Following are recent developments from Across the Consortium:

Read More

Across the Consortium – August 2017

Aug. 26, 2017: The Big Ten Cancer Research Consortium‘s Across the Consortium is your front row seat to the latest in Big Ten CRC news. This month we highlight new discoveries from our member institutions, celebrate awards, and feature outstanding researchers as well as volunteers from across the consortium.  Read More

Member Feature: Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Aug. 2, 2017: Investigator Spotlight Barbara Pro, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University Educational background: MD, University La Sapienza in Rome Italy; Residency: Mount Sinai Hospital, New York Research interests: Dr Pro’s research focus has been on the development of new therapies for the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma. She has served as the PI on numerous clinical trials, including three trials that led to the approval of novel agents for the treatment of T-cell lymphomas. Dr. Pro is an internationally renowned clinician and researcher and her work has been published extensively. Little-known facts... Read More

Across the Consortium – July 2017

July 20, 2017: Did you hear the latest news from across the Big Ten Cancer Research Consortium? While it may seem impossible to keep pace with the member institutions in their fight against cancer, you do not have to miss the action. From historic moments, to monumental studies, to game-changing discoveries, you can celebrate the latest wins every time you tune in for another monthly edition of Across the Consortium! Read More

IUSCC, Purdue host acting director of NCI; Big Ten CRC highlighted

July 16, 2017: The Indiana University Melvin and Bren Simon Cancer Center hosted Doug Lowy, the acting director of the National Cancer Institute, for a full-day visit on June 28. (Photo: Drs. Schneider (left) and Milan Radovich (middle) explain their work on the next generation of personalized medicine with Dr. Doug Lowy, acting director of the National Cancer Institute. Dr. Lowy visited the IU Simon Cancer Center on June 28. Photo credit: IU Simon Cancer Center) In a series of small-group discussions in the morning, he met with cancer center members (members' names appear in bold) and others to learn about: Pediatric genomics with D. Wade... Read More

Across the Consortium – June 2017

June 20, 2017: Summer is officially here and so is the hottest news in cancer research - at your fingertips in this month's edition of Across the Consortium. Get up to date on the latest discoveries, game-changing breakthroughs, and big-time funding achievements. Don't miss the inspirational moments that go down in history, from the dedication of the "Search" Tower to a discussion with family of Henrietta Lacks - source of the HeLa cell line.  All this and more as we take you Across the Consortium! Read More

Hershock appointed to Big Ten Cancer Research Consortium Steering Committee

June 7, 2017 The Big Ten Cancer Research Consortium recently welcomed Diane M. Hershock, MD, PhD, of Penn State Cancer Institute, as a member of its Steering Committee. The committee consists of one representative from each member institution and is responsible to decide matters of policy for the consortium. Hershock is co-director for experimental therapeutics and medical director in the Clinical Trials Office at Penn State Cancer Institute. She earned her Bachelor of Science in biology from Saint Joseph's University in Philadelphia and spent four years doing biochemistry in the thrombosis and hemostasis department at Temple University Medical School. “We were trying to develop an antibody to the GPIIb/IIIa receptor as... Read More

Member Feature: University of Michigan Comprehensive Cancer Center

June 2, 2017: Investigator Spotlight Dr. Ryan Alan Wilcox Ryan Alan Wilcox, M.D., Ph.D., assistant professor of hematology, University of Michigan Comprehensive Cancer Center  Member of the Big Ten Cancer Research Consortium Lymphoid Malignancies Clinical Trial Working Group  Interests: T-cell non-Hodgkin’s lymphomas  Medical School or Training Mayo Medical School, 2004 Residency  Mayo Clinic, Internal Medicine, MN, 2007 Fellowship Hematology/Oncology, Mayo Clinic, 2011 Board Certification Internal Medicine Medical Oncology Hematology  Read More

Experience with cancer a blessing in disguise for UW physician

May 31, 2017: Dustin Deming, MD, is a gastrointestinal oncologist at the University of Wisconsin Carbone Cancer Center (UWCCC) and the William S. Middleton Veterans Hospital with subspecialties in the treatment of colon, rectal, and anal cancers. Deming’s commitment to the field is no coincidence; his first-hand exposure to clinical oncology opened his eyes to opportunities to apply his lab science strengths. “I had thought I wanted to be a pathologist and focus mostly on basic science research, because I had kind of been a lab rat for the beginning portion of my career. Once I actually got into the clinic, I realized how exciting it was to be involved in many aspects of colorectal research: things as basic as... Read More

Big Ten cancer researchers test continuation immunotherapy with chemotherapy in advanced NSCLC

May 26, 2017: Lung cancer researchers at the Indiana University Melvin and Bren Simon Cancer Center have opened a clinical trial testing the effects of immunotherapy in combination with next-line chemotherapy in patients who experienced some benefit from immunotherapy before their disease worsened. The single-arm phase II study, known as BTCRC-LUN15-029, will enroll about 35 subjects with advanced non-small cell lung cancer who were treated with a PD-1 (programmed death-1) or PD-L1 (programmed death-ligand 1) inhibitor and experienced either stable disease or a partial or complete response before their disease worsened. The study is now open to accrual at the Indiana University... Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Wisconsin

University of Wisconsin

© 2017 All rights reserved.

Big Ten Cancer Research Consortium
500 N. Meridian Street, Suite 100, Indianapolis, IN 46204

email: info@bigtencrc.org    phone: 317–921–2050